Literature DB >> 20433950

Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab.

Francesco Ursini, Saverio Naty, Valerio Mazzei, Francesco Spagnolo, Rosa Daniela Grembiale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433950     DOI: 10.1016/j.intimp.2010.04.016

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


× No keyword cloud information.
  10 in total

1.  An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis.

Authors:  Francesca Ambrogio; Carmelo Laface; Federico Perosa; Lucia Lospalluti; Girolamo Ranieri; Serena De Prezzo; Marcella Prete; Gerardo Cazzato; Fabrizio Guarneri; Paolo Romita; Caterina Foti
Journal:  Intern Emerg Med       Date:  2022-07-04       Impact factor: 3.397

2.  H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; G Guggino; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

3.  Hidden Pictures of Kaposi's Sarcoma in Psoriatic Lesions: A Diagnostic Challenge.

Authors:  Jisook Yoo; Mingyul Jo; Min-Soo Kim; Kwang-Hyun Choi; Hyang-Joon Park; Mihn-Sook Jue
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

4.  Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.

Authors:  Piero Ruscitti; Francesco Ursini; Paola Cipriani; Francesco Ciccia; Vasiliki Liakouli; Francesco Carubbi; Giuliana Guggino; Onorina Berardicurti; Rosadaniela Grembiale; Giovanni Triolo; Giovambattista De Sarro; Roberto Giacomelli
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.

Authors:  Piero Ruscitti; Francesco Ursini; Paola Cipriani; Vasiliki Liakouli; Francesco Carubbi; Onorina Berardicurti; Giovambattista De Sarro; Roberto Giacomelli
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

Review 6.  Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.

Authors:  Eleonora Ruocco; Vincenzo Ruocco; Maria Lina Tornesello; Alessio Gambardella; Ronni Wolf; Franco M Buonaguro
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

7.  Iatrogenic Kaposi Sarcoma Precipitated by Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy.

Authors:  Aathi Lakshmi Mariappan; Shreya Desai; Alberto Locante; Palak Desai; Javairia Quraishi
Journal:  Cureus       Date:  2021-02-16

8.  Unusual Presentation of Kaposi Sarcoma During Adalimumab Therapy: a Case Report.

Authors:  Gulsun-Hazan Tabak; Basak Yalici-Armagan; Burkay-Adem Sahin; Ozay Gokoz; Sedat Kiraz
Journal:  Dermatol Pract Concept       Date:  2022-07-01

9.  Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.

Authors:  Francesca Ingegnoli; Athanasia Tourlaki; Roberta Gualtierotti
Journal:  Clin Drug Investig       Date:  2014-02       Impact factor: 3.580

Review 10.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.